0.0306
-0.0034 (-10.0%)
-0.0034 (-10.0%)
Upgrade to Real-Time
Market Closed
| Volume | 2,789,600 |
|
|||||
| News | - | ||||||
| Day High | 0.034 | Low High |
|||||
| Day Low | 0.029 | ||||||
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Elite Pharmaceuticals Inc (QB) | ELTP | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.0034 | -10.0% | 0.0306 | 17:20:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.034 | 0.029 | 0.034 | 0.0306 | 0.034 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 121 | 2,789,600 | $ 0.030642 | $ 85,480 | - | 0.029 - 0.0924 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 2,500 | $ 0.0306 | USD |
Period:
Draw Mode:
Elite Pharmaceuticals Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 30.95M | 1.01B | 750.39M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 12.25k | $ - | - | - | - |
Elite Pharmaceuticals (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELTP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.036 | 0.04 | 0.029 | 0.0341108 | 1,272,124 | -0.0054 | -15.0% |
| 1 Month | 0.0361 | 0.042 | 0.029 | 0.0364218 | 946,424 | -0.0055 | -15.24% |
| 3 Months | 0.0425 | 0.0489 | 0.029 | 0.0402261 | 895,533 | -0.0119 | -28.0% |
| 6 Months | 0.054 | 0.06 | 0.029 | 0.0452543 | 873,828 | -0.0234 | -43.33% |
| 1 Year | 0.0535 | 0.0924 | 0.029 | 0.0541708 | 1,041,734 | -0.0229 | -42.8% |
| 3 Years | 0.082 | 0.141 | 0.029 | 0.0694119 | 889,567 | -0.0514 | -62.68% |
| 5 Years | 0.14 | 0.2495 | 0.029 | 0.091394 | 891,916 | -0.1094 | -78.14% |
Elite Pharmaceuticals (QB) Description
| Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, TAGI Pharma, and Glenmark Pharmaceuticals, Inc. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. |
